-
Symbol
-
PTIX on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.0001 per share
-
Latest Disclosed Shares Owned
-
240,000 shares
-
Security Ownership %
-
3.4%
Armistice Capital, LLC ownership in Protagenic Therapeutics, Inc.\new Common Stock, par value $0.0001 per share (PTIX)
14 Feb 2025 - Armistice Capital, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 240,000 shares of Protagenic Therapeutics, Inc.\new Common Stock, par value $0.0001 per share (PTIX).
This represents 3.4% ownership of the company.
This is the first filing by ARMISTICE CAPITAL, LLC disclosing ownership of Protagenic Therapeutics, Inc.\new Common Stock, par value $0.0001 per share (PTIX).